Back to results
US 9,750,786 B2Granted
Treatment of thrombocytopenia using orally administered interferon
AssigneeAmarillo Biosciences, Inc.
InventorsMartin Joseph Cummins, Chau-Ting Yeh, Ching-Yuan Lee
Life of this patent
Estimating the term…
Abstract
An interferon composition is provided for enhancing the platelet count, reducing the recurrence rate of hepatitis, and/or improving the social function of hepatitis patients. The method comprises administering a low dose of IFN (about 5 IU to about 2500 IU of IFN-alpha) to a patient in need thereof. In one embodiment the IFN is alpha IFN or beta IFN, and more particularly, in one embodiment the administered biologically active IFN is human alpha IFN.
Claims9
A method of enhancing the platelet count of a patient having thrombocytopenia, the method comprising:
- identifying a patient with platelet blood levels of less than 150,000 platelets per microliter,
- wherein the normal level of blood platelets in the patient is at or above 150,000 platelets per microliter, and
- orally administering a daily dosage of about 500 IU of interferon-alpha to the patient to stimulate a more rapid increase of blood platelets to a normal level of blood platelets in the patient.
Dependencies are inferred from the claim text.